» Articles » PMID: 26551289

Toward the Replacement of Animal Experiments Through the Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures

Overview
Journal Altern Lab Anim
Publisher Sage Publications
Date 2015 Nov 10
PMID 26551289
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

This paper outlines the work for which Roland Grafström and Pekka Kohonen were awarded the 2014 Lush Science Prize. The research activities of the Grafström laboratory have, for many years, covered cancer biology studies, as well as the development and application of toxicity-predictive in vitro models to determine chemical safety. Through the integration of in silico analyses of diverse types of genomics data (transcriptomic and proteomic), their efforts have proved to fit well into the recently-developed Adverse Outcome Pathway paradigm. Genomics analysis within state-of-the-art cancer biology research and Toxicology in the 21st Century concepts share many technological tools. A key category within the Three Rs paradigm is the Replacement of animals in toxicity testing with alternative methods, such as bioinformatics-driven analyses of data obtained from human cell cultures exposed to diverse toxicants. This work was recently expanded within the pan-European SEURAT-1 project (Safety Evaluation Ultimately Replacing Animal Testing), to replace repeat-dose toxicity testing with data-rich analyses of sophisticated cell culture models. The aims and objectives of the SEURAT project have been to guide the application, analysis, interpretation and storage of 'omics' technology-derived data within the service-oriented sub-project, ToxBank. Particularly addressing the Lush Science Prize focus on the relevance of toxicity pathways, a 'data warehouse' that is under continuous expansion, coupled with the development of novel data storage and management methods for toxicology, serve to address data integration across multiple 'omics' technologies. The prize winners' guiding principles and concepts for modern knowledge management of toxicological data are summarised. The translation of basic discovery results ranged from chemical-testing and material-testing data, to information relevant to human health and environmental safety.

Citing Articles

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework.

Nymark P, Sachana M, Batista Leite S, Sund J, Krebs C, Sullivan K Front Public Health. 2021; 9:638605.

PMID: 34095051 PMC: 8170012. DOI: 10.3389/fpubh.2021.638605.


High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures.

Franzosa J, Bonzo J, Jack J, Baker N, Kothiya P, Witek R NPJ Syst Biol Appl. 2021; 7(1):7.

PMID: 33504769 PMC: 7840683. DOI: 10.1038/s41540-020-00166-2.


Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.

Halappanavar S, van den Brule S, Nymark P, Gate L, Seidel C, Valentino S Part Fibre Toxicol. 2020; 17(1):16.

PMID: 32450889 PMC: 7249325. DOI: 10.1186/s12989-020-00344-4.


Transcriptomics in Toxicogenomics, Part II: Preprocessing and Differential Expression Analysis for High Quality Data.

Federico A, Serra A, Ha M, Kohonen P, Choi J, Liampa I Nanomaterials (Basel). 2020; 10(5).

PMID: 32397130 PMC: 7279140. DOI: 10.3390/nano10050903.


Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects.

Kinaret P, Serra A, Federico A, Kohonen P, Nymark P, Liampa I Nanomaterials (Basel). 2020; 10(4).

PMID: 32326418 PMC: 7221878. DOI: 10.3390/nano10040750.